Jump to content
  • DemodexSolutionsLogo.jpg

    Demodex Solutions is one of our sponsors who provides treatments for demodectic rosacea and we have an affiliate relationship. For a list of all the Demodex Solutions products click here. By clicking on any of the images below and purchasing an item the RRDi gets a small affiliate fee. Mahalo for purchasing Demodex Solutions products through the RRDi. 

    Please Note: For a limited time, Demodex Solutions is offering a free trial of samples of a new ZZ cream formulated for dry skin. If you are interested in obtaining these samples shipped to your address please read this post

    Zhongzhou_big2.jpgxin.pngnewfumanling_big.jpgzzcleanser.jpg

  • Posts

    • Related Articles Evaluation of Demodex mite viability using motility and scattered light intensity. Exp Appl Acarol. 2019 Apr 19;: Authors: Gatault S, Foley R, Shiels L, Powell FC Abstract Demodex mites have been suggested to have a role in various cutaneous and ocular disorders pathogenesis, such as rosacea or blepharitis. Evaluation of potential treatments with anti-Demodex effects is difficult because the viability of living mites needs to be evaluated during their exposure to the agent being tested. Mite viability is currently based solely on their observed movement. However, this method of assessing viability has significant limitations as mites may be resting, immobile or paralysed at any given observation point giving the observer a false impression of the organism's death. To overcome this limitation we evaluated a new quantitative method of evaluating the viability of Demodex mites by using scattered light intensity (SLI). We demonstrated that when combined with observation of mite motility, SLI provided increased accuracy of the evaluation of viability of mites being studied. This new viability assay will help address the technical challenges of mite viability experiments. Accurate evaluation of mite viability will enhance mite biology research and allow for more accurate in vitro toxicity assays of proposed anti-mite agents. PMID: 31001698 [PubMed - as supplied by publisher] {url} = URL to article
    • Nonvascular uses of pulsed dye laser in clinical dermatology. J Cosmet Dermatol. 2019 Apr 19;: Authors: Forbat E, Al-Niaimi F Abstract Lasers are fast becoming the vogue of dermatology ranging from ablative, nonablative, fractional photothermolysis to vascular lasers. There are a range of vascular lasers including potassium titanyl phosphate (KTP 532 nm), pulsed dye laser (PDL -595 nm), diode (810 nm), and Nd:YAG (1064 nm). PDL is a laser that emits yellow light using Rhodamine dye as it is lasing medium. Typical vascular lesions which are treated by PDL include port wine stain, hemangioma, telangiectasia, spider angioma, and rosacea. This article focuses on the use of PDL beyond primary vascular conditions. We review the evidence, or lack thereof, of the use of PDL in acne vulgaris, scars, striae, warts, molluscum, psoriasis, rejuvenation, basal cell carcinoma (BCC), and miscellaneous dermatological sequelae. PMID: 31002479 [PubMed - as supplied by publisher] {url} = URL to article
    • Sol-Gel Technologies LTD is continuing its clinical trial with its generic ivermectin cream and has also released information on Epsolay for papulopustular rosacea, which is the first micro-encapsulated single active benzoyl peroxide (5%)  prescription drug. For more information or download here:  0001178913-19-000060.pdf
×
×
  • Create New...